Edgewise Therapeutics neuromuscular business Acquired by Servier | Healthcare M&A Deal

Servier has acquired Edgewise Therapeutics neuromuscular business, a healthcare services other business in the United States. Edgewise Therapeutics’ neuromuscular programs focus on developing treatments for rare neurological conditions, supporting Servier’s neurology pipeline with potential first-in-class therapies. Servier acquisitions in neurology align with its patient-first operating model and expand capabilities in neuromuscular disease areas. The strategic acquisition is structured as a divestiture acquisition, with deal size undisclosed and the transaction announced for completion following signing.